Transcatheter intraarterial perfusion: MR monitoring of chemoembolization for hepatocellular carcinoma-feasibility of initial clinical translation
Transcatheter intraarterial perfusion: MR monitoring of chemoembolization for hepatocellular carcinoma-feasibility of initial clinical translation
复制标题
DOI:
10.1148/radiol.2463070725
复制
发表时间:
2008-03-01
期刊:
影响因子:
19.7
通讯作者:
Omary, Reed A.
中科院分区:
文献类型:
--
作者:
Larson, Andrew C.;Wang, Dingxin;Omary, Reed A.
Purpose: To prospectively test the hypothesis that intraprocedural transcatheter intraarterial perfusion (TRIP) magnetic resonance (MR) imaging can be used to successfully measure reductions in perfusion to the targeted hepatocellular carcinoma (HCC) and the adjacent. surrounding liver tissue during NAR-interventional radiology (IR)-monitored transcatheter arterial chemoembolization (TACE).Materials and methods: This HIPPA-compliant prospective study was approved by the institutional review board. An MR-IR unit was used to Perform TACE in 10 patients with HCC (seven male, three female; eight younger than 69 years, two older, than 69 years). Intraprocedural reductions in tumor perfusion before and after TACE were monitored with TRIP MR imaging. Time-signal intensity curves were derived, and semi-quantitative spatially resolved area under the time-signal intensity curve maps of tumor perfusion before and after r TACE were produced. Mean perfusion values before and after TACE for liver tumors and adjacent liver tissue were compared by using a mixed-model analysis, with alpha = 05.Results: Perfusion reductions were measured successfully with TRIP MR imaging in 18 separate tumors during 13 treatment sessions. Perfusion maps showed significant perfusion reductions for tumors (P